Loading company
Latest annual · FY2021
Millions- Operating income
- (2)
- Net income
- (7)
Latest quarter · Q3 FY2022
Millions- Operating income
- (0)
- Net income
- 1
Biotech Acquisition Co financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.6 million | 10-K 2022-03-08 · proof | ||
| Net income | -$6.9 million | 10-K 2022-03-08 · proof | ||
| Cash from operating activities | -$1.5 million | 10-K 2022-03-08 · proof | ||
| Total assets | $230.3 million | $89,500 | +257,241.6% | 10-K 2022-03-08 · proof |
| Total liabilities | $27.5 million | $69,500 | +39,424% | 10-K 2022-03-08 · proof |
| Cash and cash equivalents | $91,407 | 10-K 2022-03-08 · proof |
- What was Biotech Acquisition Co's operating income in fiscal 2021?
- Biotech Acquisition Co reported operating income of -$1.6 million for fiscal 2021 (the year ended Dec 31, 2021). Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
- What was Biotech Acquisition Co's net income in fiscal 2021?
- Biotech Acquisition Co reported net income of -$6.9 million for fiscal 2021 (the year ended Dec 31, 2021). Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
- What was Biotech Acquisition Co's cash from operating activities in fiscal 2021?
- Biotech Acquisition Co reported cash from operating activities of -$1.5 million for fiscal 2021 (the year ended Dec 31, 2021). Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
- What are Biotech Acquisition Co's total assets?
- As of Dec 31, 2021, Biotech Acquisition Co reported total assets of $230.3 million, against $89,500 a year earlier (+257,241.6%). Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
- What are Biotech Acquisition Co's total liabilities?
- As of Dec 31, 2021, Biotech Acquisition Co reported total liabilities of $27.5 million, against $69,500 a year earlier (+39,424%). Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
- What are Biotech Acquisition Co's cash and cash equivalents?
- As of Dec 31, 2021, Biotech Acquisition Co reported cash and cash equivalents of $91,407. Source: the 10-K filed with the SEC on Mar 8, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1825413&period_type=annual&limit=5"Information only, not investment advice.